FDA Warning Wire: OTC Drug Dangers, Lead Contamination

Law360, New York (March 22, 2016, 7:53 PM EDT) -- FDA inspectors on Tuesday let loose with springtime smackdowns, warning of severe risks posed by an over-the-counter asthma drug, alleging lead contamination in a popular skin product and threatening to shutter a mammography clinic over imaging violations. Here's a look at the agency's latest enforcement actions.

Discipline Targets 'Possibly Fatal' Asthma Drug

One of Tuesday's strongest warning letters went to Delaware-based Dr. Natural Healing, which sells bronchodilators over the counter in drugstores. At issue are epinephrine powder capsules used in inhalers, with the FDA saying that the combined formulation and usage isn't recognized as safe and effective.

In its letter, the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS